Ulrich Spengler, managing director of altona Diagnostics GmbH, and his partners Markus Hess and the late Thomas Laue from the R & D department share a long-time experience in molecular diagnostics, especially in infectious diseases, dating back to their common years spent at the Bernhard-Nocht-Institute for Tropical Medicine in Hamburg, Germany.
Part of the portfolio of diagnostic test systems for tropical and emerging infectious diseases has been developed in collaboration with the Bernhard-Nocht-Institute for Tropical Medicine, Hamburg, co-funded by the European Fund for Regional Development (ERDF) Hamburg.
Following this tradition the altona Diagnostics team actively develops and commercializes new molecular diagnostic assays – fast, flexible, reliable and close to the customer needs – as an answer to common and emerging infectious diseases.
artus Diagnostics, spin-off from Bernhard-Nocht-Institute for Tropical Medicine in Hamburg, Germany
Acquisition of artus by Qiagen
Foundation of astra Diagnostics
astra Diagnostics becomes altona Diagnostics
Subsidiaries in USA and Canada
Foundation of altona Diagnostics France
altona Diagnostics gets a new layout
Subsidiaries in Argentina, Brazil, UK and India
Subsidiary altona Diagnostics USA, Inc. moves from San Francisco to Columbus Metro Area, Ohio